Latest News about KVUE
Recent news which mentions KVUE
3 Dividend-Paying Value Stocks to Buy Even If There's a Stock Market Sell-Off in 2025
December 29, 2024
From Motley Fool
A Bull Market Is Here: 2 Super Stocks Down 21% and 30% to Buy Right Now
December 23, 2024
From Motley Fool
Critical Insights From Kenvue Analyst Ratings: What You Need To Know
December 12, 2024
Tickers
KVUE
From Benzinga
Coca-Cola cs. Procter & Gamble: Which Is the Better Dow Dividend King Stock to Buy Before the End of the Year?
December 08, 2024
From Motley Fool
Like Passive Income? Then You'll Love These 3 Super Safe Dividend Stocks That Are Up Between 28% and 42% in 6 Months.
December 04, 2024
From Motley Fool
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
November 08, 2024
From Benzinga
Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin Health And Beauty Sales
November 07, 2024
From Benzinga
This Big New Development Could Be Bullish for Kenvue Stock
October 30, 2024
Tickers
KVUE
From Motley Fool
3 Dividend Stocks to Double Up on Right Now
October 27, 2024
From Motley Fool
Billionaire Ken Griffin Just Increased His Position in This Dividend Stock by 5,848%. Here's Why Now May Be a Great Time to Buy.
October 26, 2024
Tickers
KVUE
From Motley Fool
Meet the 3.6%-Yielding Dividend King Stock That's Up 25% in 3 Months
October 26, 2024
Tickers
KVUE
From Motley Fool
What's Going On With Kenvue Stock Monday?
October 21, 2024
From Benzinga
Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday?
October 21, 2024
From Benzinga
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff?
October 20, 2024
From Benzinga
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year
October 13, 2024
From Motley Fool
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
October 11, 2024
From Benzinga
P/E Ratio Insights for Kenvue
September 27, 2024
From Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
From Benzinga
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
September 10, 2024
From Benzinga
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
September 01, 2024
From Motley Fool
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
August 31, 2024
From Benzinga
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
August 30, 2024
From Benzinga
Donald Trump Owns These 21 Dividend Kings. Should You?
August 26, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.